BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Rejenevie Therapeutics

Rejenevie Therapeutics logo

United States of America based

Rejenevie™ is developing a heterochronic cell culture model to stimulate the function of hematopoietic stem cells (HSCs). The Rejenevie™ approach uses the hematopoietic and immune systems as a model to identify differential relationships between youthful and aged systems, providing a way to isolate restorative factors that target key causal aging mechanisms. The result is new therapies and interventions that can prevent or delay aging-related diseases.


Aging Research   Stem Cells Startups  

R&D Platform


No pipelines published yet




No services posted yet